Project Grant R21HD112649

Award Date 8/1/24
Completion Date 7/31/26
Dollars Obligated $432K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
This $107,860 Project Grant, awarded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to understand the functional role of fibroid subtype mutations in developing new targeted therapies for uterine fibroids. The research aims to 1) determine the functional roles of HMGA2 over-expression and MED12 mutation in uterine fibroids, 2) predict and test drug compounds to target...
The National Institute of Child Health and Human Development (NICHD) awarded a 5-year, $1,624,100 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Kansas Medical Center Research Institute, Inc. The goal of this project is to understand the role of the tumor suppressors REST and MED12 in regulating estrogen and progesterone pathways in uterine fibroids. The research aims to define molecular hallmarks for developing selective...
This $2,121,229 Project Grant, awarded by the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research, supports research to evaluate the impact of altered gene expression on uterine fibroid risk among women of African ancestry. The key objectives are to: 1) test for associations between known and novel fibroid genetic risk loci and gene expression in Nigerian women, 2) detect cell-specific gene expression...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to Northwestern University provides USD 681,337 to support research on the STAT3 pathway as a therapeutic target for uterine leiomyoma (fibroids). The research aims to: Determine the functional role of the STAT3 pathway in leiomyoma growth in vivo using a patient-derived xenograft mouse model, and Define the cell populations and underlying epigenetic/transcriptomic processes responsible for...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research, aims to evaluate the effect of exogenous anti-Müllerian hormone (AMH) on ovarian function and fertility in non-human primates. The $724,714 award will support research to test hypotheses that AMH can induce contraception without disrupting estradiol homeostasis, reduce ovarian aging, and potentially...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $390,000 to Thomas Jefferson University (Sidney Kimmel Medical College) to evaluate the use of contrast-enhanced ultrasound (CEUS) and subharmonic-aided pressure estimation (SHAPE) techniques for assessing uterine fibroids before and after uterine artery embolization (UAE) procedures. The goals...
This Project Grant award of $848,100 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund research to investigate the cellular mechanisms underlying recurrent vaginal prolapse after prolapse surgery. The primary objectives are to: 1) Examine the effect of pelvic organ prolapse (POP) surgery on the human vagina through tissue biomechanical testing,...
This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a study to assess the impact of uterine fibroids on the in-utero environment and long-term cardiometabolic health of offspring. The $100,170 award to The Johns Hopkins University will leverage the existing Boston Birth Cohort to investigate: 1) the risk of maternal vascular malperfusion and...
This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $629,998 to Worcester Polytechnic Institute to develop in vitro models for investigating the biophysical and biochemical drivers of fibrosis progression and regression across diverse engineered platforms. The project aims to create models for pancreatic, skin, and uterine fibroid fibrosis to advance understanding of how tissue-specific extracellular matrix features, cellular composition,...
The National Institute of Child Health and Human Development (NICHD) awarded a $704,154 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to Oregon Health & Science University (OHSU). The purpose of this 5-year study is to investigate how maternal diet-induced metabolic dysfunction impacts epigenetic programming and developmental processes in rhesus macaque embryos and fetuses. Specifically, the researchers will assess alterations in DNA...

DEVELOPING A BABOON MODEL FOR UTERINE FIBROIDS - BY AGE 50, MOST WOMEN WILL HAVE HAD UTERINE LEIOMYOMAS (FIBROIDS) WITH A LIFETIME CUMULATIVE INCIDENCE OF ~70% FOR WHITE WOMEN AND >80% FOR BLACK WOMEN. APPROXIMATELY 25% OF WOMEN WITH FIBROIDS EXPERIENCE SYMPTOMS SEVERE ENOUGH TO CAUSE THEM TO SEEK CLINICAL CARE. ALTHOUGH THEY ARE A SIGNIFICANT HEALTHCARE BURDEN FOR MANY INDIVIDUALS, THE ETIOLOGY AND PATHOPHYSIOLOGY OF FIBROIDS IS POORLY UNDERSTOOD. FIBROIDS ARE THE MOST COMMON REASON FOR HYSTERECTOMY IN THE US, YET FIBROID INCIDENCE AND SYMPTOMATOLOGY ARE POORLY UNDERSTOOD. THE CURRENT GAP IN KNOWLEDGE ABOUT THE ETIOLOGY AND PATHOPHYSIOLOGY OF THE DISEASE HAS CONTRIBUTED TO THE LACK OF SAFE AND EFFECTIVE LONG-TERM STRATEGIES FOR WOMEN WITH THE DISEASE. VERY LITTLE IS KNOWN ABOUT THE UNDERLYING MECHANISMS THAT LEAD TO FIBROID DEVELOPMENT. ONE OF THE MAIN REASONS THAT FIBROID BIOLOGY IS POORLY UNDERSTOOD IS THE LACK OF A GOOD MODEL SYSTEM TO STUDY THE DISEASE. PERHAPS, THE BEST MODEL AVAILABLE IS A KIDNEY CAPSULE XENOGRAFT MODEL IN IMMUNOCOMPROMISED MICE BUT THEIR TRANSLATIONAL POTENTIAL IS NOT CLEAR. SEVERAL OTHER ANIMAL MODELS, INCLUDING SOME GENETICALLY MODIFIED MICE, HAVE BEEN PROPOSED FOR FIBROID RESEARCH, BUT EACH HAS SIGNIFICANT LIMITATIONS THAT PREVENT THEIR WIDESPREAD USE IN THE LABORATORY. OUR GOAL IS TO DEVELOP A STANDARDIZED AND RELIABLE ORTHOTOPIC BABOON MODEL FOR UTERINE FIBROID RESEARCH, WHICH WE PROPOSE TO DO IN TWO PHASES. THERE ARE SEVERAL REASONS FOR CHOOSING THE BABOON FOR THIS PURPOSE. THE BABOON IS NOT ENDANGERED, HAS BEEN USED BY MANY LABORATORIES TO STUDY REPRODUCTIVE BIOLOGY BECAUSE OF THE SPECIES PHYLOGENETIC SIMILARITY TO HUMANS AND MOST IMPORTANTLY, BABOONS DEVELOP SPONTANEOUS UTERINE FIBROIDS, THEMSELVES, A TRAIT SHARED BY ALL PRIMATES EXAMINED. IN PHASE 1 OF THE PROJECT, WE PROPOSE TO DEVELOP STABLE, IMMORTALIZED, AND CLONAL BABOON MYOMETRIAL CELL LINES THAT MIMIC UTERINE FIBROID CELLS FROM HUMAN AS CLOSELY AS POSSIBLE WITH THE FOLLOWING AIMS: ESTABLISH BABOON IMMORTALIZED MYOMETRIAL CELL LINES THAT CORRESPOND TO THE MOST COMMON GENETIC SUBTYPES OBSERVED IN HUMAN FIBROIDS AND PERFORM IN VITRO AND IN VIVO ASSAYS TO SELECT THE MOST PROMISING CELL LINES FOR TRANSPLANTATION INTO BABOON HOSTS. SUCCESSFUL COMPLETION OF THESE AIMS WILL ALLOW US TO APPLY FOR R01 FUNDING TO PERFORM PHASE 2 OF THE PROJECT, THE ORTHOTOPIC ALLOGRAFT ASSAYS BABOONS WITH OUR COLLABORATORS.

Posted 7/29/24, 12:00 AM